Globus Medical (NYSE: GMED) director exercises options, sells 25,000 shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Globus Medical director David D. Davidar reported an exercise-and-sell transaction in Class A common stock. He exercised stock options for 25,000 shares at $26.27 per share and sold 25,000 shares in an open-market transaction at a weighted average price of $80.7629 per share.
Following these moves, Davidar directly holds 510,175 shares of Class A common stock. In addition, a family irrevocable trust established on August 6, 2009 holds 165,967 shares for the benefit of his spouse and children, with his spouse serving as trustee.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 25,000 shares ($2,019,073)
Net Sell
4 txns
Insider
Davidar David D
Role
null
Sold
25,000 shs ($2.02M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy Class A Common Stock) | 25,000 | $0.00 | -- |
| Exercise | Class A Common Stock | 25,000 | $26.27 | $657K |
| Sale | Class A Common Stock | 25,000 | $80.7629 | $2.02M |
| holding | Class A Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy Class A Common Stock) — 0 shares (Direct, null);
Class A Common Stock — 535,175 shares (Direct, null);
Class A Common Stock — 165,967 shares (Indirect, By Davidar Family Irrevocable Trust U/A 8/6/09)
Footnotes (1)
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at a price range of $80.59 - $80.92, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in footnote (1) of this Form 4. These shares are held in a trust for the benefit of the reporting person's spouse and children. The reporting person's spouse is trustee of the trust. These options were granted on January 30, 2017 and are fully vested.
Key Figures
Shares sold: 25,000 shares
Sale price (weighted average): $80.7629 per share
Options exercised: 25,000 shares
+4 more
7 metrics
Shares sold
25,000 shares
Class A Common Stock open-market sale on 2026-06-05
Sale price (weighted average)
$80.7629 per share
Open-market sale price range $80.59–$80.92
Options exercised
25,000 shares
Stock option exercise on 2026-06-05
Option exercise price
$26.27 per share
Stock option (Right to Buy Class A Common Stock)
Direct holdings after transactions
510,175 shares
Class A Common Stock directly owned after 2026-06-05
Indirect trust holdings
165,967 shares
Held by Davidar Family Irrevocable Trust U/A 8/6/09
Derivative position remaining
0 options
Stock option balance after 25,000-share exercise
Key Terms
weighted average price, open-market sale, Stock Option (Right to Buy Class A Common Stock), irrevocable trust, +1 more
5 terms
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
open-market sale financial
"transaction_action: open-market sale"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Stock Option (Right to Buy Class A Common Stock) financial
"security_title: Stock Option (Right to Buy Class A Common Stock)"
irrevocable trust financial
"By Davidar Family Irrevocable Trust U/A 8/6/09"
An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.
fully vested financial
"These options were granted on January 30, 2017 and are fully vested."
FAQ
What did Globus Medical (GMED) director David D. Davidar report in this Form 4?
David D. Davidar reported exercising stock options for 25,000 Globus Medical shares at $26.27 and selling 25,000 shares in an open-market transaction at a weighted average price of $80.7629, reflecting a routine exercise-and-sell pattern.
What stock options did Davidar exercise in this Globus Medical (GMED) filing?
Davidar exercised stock options covering 25,000 shares of Globus Medical Class A common stock at an exercise price of $26.27 per share. The options were originally granted on January 30, 2017 and were fully vested at the time of exercise, according to the disclosure.
What are Davidar’s direct and indirect Globus Medical (GMED) holdings after the transactions?
After the reported transactions, Davidar directly holds 510,175 shares of Globus Medical Class A common stock. Additionally, a family irrevocable trust for his spouse and children holds 165,967 shares, which are reported as indirectly owned through that trust arrangement.